RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.
about
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growthEpithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigensMolecular and Translational Classifications of DAMPs in Immunogenic Cell Death.IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity.Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells2'Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors.CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer ImmunotherapyImmunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1.RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer.Strategies to relieve immunosuppression in pancreatic cancer.RIG-I activation induces the release of extracellular vesicles with antitumor activity.Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysisCytokines in immunogenic cell death: Applications for cancer immunotherapy.Mechanisms regulating immune surveillance of cellular stress in cancer.DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinoma.Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancer.Regulation of tumor-stroma interactions by the Unfolded Protein Response.Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies.Digital signaling network drives the assembly of the AIM2-ASC inflammasome.Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults.A minimal RNA ligand for potent RIG-I activation in living mice.Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.Differential Induction of Immunogenic Cell Death and Interferon Expression in Cancer Cells by Structured ssRNAs.Fascin1 suppresses RIG-I-like receptor signaling and interferon-β production by associating with IκB kinase ϵ (IKKϵ) in colon cancer.Effects of retinoic acid-inducible gene-I-like receptors activations and ionizing radiation cotreatment on cytotoxicity against human non-small cell lung cancer in vitro.Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment.
P2860
Q30842176-663B10A9-EA43-48AF-9EE1-1E715C05375EQ35870150-AE1554F9-A262-42BB-8142-3B9D2186EA0CQ36301061-55593C03-2E41-422B-9544-187097F75A48Q36346936-653D5C6B-E499-4BFE-95A6-5AA1F50766FBQ36532695-F0C15A74-C74C-487D-8532-1A7F5BA38CBAQ36987499-CBCFDB3C-C945-4118-84AE-61C52B890548Q37130209-B059C0CC-A767-4BA8-B9C7-75DE3BC99700Q37536659-46C38A76-7DA9-4327-9C01-F3A5B88D44C2Q37566592-C0BDCA46-0B3A-4045-B24D-F9D72A6819DCQ38445328-112326DD-B75E-431C-992D-31197FA48A1BQ39181844-E7AA8DB6-407A-4987-B173-00E812727697Q39281286-A5D2FF53-926A-44C9-9CD8-7704C8D7560DQ39397491-A6F83610-3F70-4831-A1E2-AC9E9D0B8EB2Q39458697-419DB999-45E6-4630-95E3-13D330EEB8C2Q40579130-D8607897-4455-478C-9141-C3E8DBEFED07Q41182217-76CB8E25-F517-44A7-B463-B208261535F1Q41857672-B889B093-394F-4361-825A-B2473FBE7FDDQ46556374-FDD22285-F294-4CD2-9D7C-C4ACABE2EDE2Q47548653-E99CB57B-0583-4DE3-8A28-B770D84F7B1AQ50026373-B95441F5-B4AF-4D8E-AE52-FF72D4CFD3BBQ50324081-9D358C02-7765-428D-A3F4-E8C27375AFFBQ50335102-E99A655C-766F-4F6F-99E5-DB38174132D5Q52568331-33F6D78D-F109-48A1-BC48-AE7399C6EF6AQ53382317-B7A693C1-D104-46BC-83D8-97C5B7C5E825Q54123544-DF9AB0A9-E9E9-4CF4-8350-27148BB0609FQ55396166-B15B29FF-8000-4383-9251-DDBE18D778E5Q55508841-3DDCDEF6-663D-478D-A69B-D499753889C1
P2860
RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
RIG-I-like helicases induce im ...... e tumors toward killing by CD8
@nl
RIG-I-like helicases induce im ...... ard killing by CD8(+) T cells.
@ast
RIG-I-like helicases induce im ...... ard killing by CD8(+) T cells.
@en
type
label
RIG-I-like helicases induce im ...... e tumors toward killing by CD8
@nl
RIG-I-like helicases induce im ...... ard killing by CD8(+) T cells.
@ast
RIG-I-like helicases induce im ...... ard killing by CD8(+) T cells.
@en
prefLabel
RIG-I-like helicases induce im ...... e tumors toward killing by CD8
@nl
RIG-I-like helicases induce im ...... ard killing by CD8(+) T cells.
@ast
RIG-I-like helicases induce im ...... ard killing by CD8(+) T cells.
@en
P2093
P2860
P356
P1476
RIG-I-like helicases induce im ...... ard killing by CD8(+) T cells.
@en
P2093
J T Siveke
S Grassmann
P2860
P2888
P304
P356
10.1038/CDD.2014.96
P577
2014-07-11T00:00:00Z
P5875
P6179
1029099317